JCOVDEN® (previously COVID-19 Vaccine Janssen)
COVID-19 vaccine (Ad26.COV2-S [recombinant])

patient icon

I'm not a healthcare professional

Discoverchevron right
hcp icon

I'm a healthcare professional

Discover chevron right

Side Effects Reporting

For suspected side effects, please contact your National Health Authority:

Medicines Authority

More Information

For any additional information about this medicine, please contact the local representative of the Marketing Authorisation Holder:

Local number:

+356 2397 6000
covid image

 

Janssen-Cilag Pharmaceutical S.A.C.I.

 

56, Leof. Eirinis 

151 21 Pefki 

Athens

Greece

 

Nov-2022, CP-308345